Cargando…
Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study
Low dose naltrexone (LDN) has become a popular off-label therapy for multiple sclerosis (MS). A few small, randomized studies indicate that LDN may have beneficial effects in MS and other autoimmune diseases. If proven efficacious, it would be a cheap and safe alternative to the expensive treatments...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669439/ https://www.ncbi.nlm.nih.gov/pubmed/29099849 http://dx.doi.org/10.1371/journal.pone.0187423 |